世界のドラッグデリバリー市場予測 2022-2030年

出版:Inkwood Research(インクウッドリサーチ) 出版年月:2022年1月

GLOBAL DRUG DELIVERY MARKET FORECAST 2022-2030

世界のドラッグデリバリー市場予測 2022-2030年

ページ数 366
価格
シングルユーザライセンス USD 2,500
マルチユーザライセンス USD 3,000
エンタープライズライセンス USD 4,500
種別 英文調査報告書

レポート目次  見積ご依頼・お問合せ  ご購入案内

無料サンプル

KEY FINDINGS
The global drug delivery market is projected to record a CAGR of 6.84% during the estimated years of 2022 to 2030. The market growth is mainly reinforced by the increasing usage of biological drugs, technical advancements in drug delivery techniques, the increasing incidence of chronic conditions and prevailing aging population, as well as the rising need for effective drug delivery mechanisms.
MARKET INSIGHTS
Drug delivery entails the process of administering a pharmaceutical compound in order to provide therapy for various conditions. These drug delivery technologies alter the profile of drug releases, such as distribution, absorption, and elimination for the improvement of product safety and efficacy. It also considers patient convenience as well as compliance with the drug. The common routes of administration include oral, enteral, inhalation, parenteral, topical, and transdermal patches routes.
Technological advancements in the avenue of drug delivery technology are one of the leading factors propelling the global market’s growth. In addition, the introduction of novel delivery platforms is anticipated to introduce solutions that optimize a drug’s therapeutic value, thus finding a relatively improved approach to get a drug into the patient’s body consistently and safely. As a result, this aspect leads to improved compliance and outcomes.
REGIONAL INSIGHTS
The global drug delivery market growth assessment includes the analysis of North America, Europe, Asia-Pacific, and Rest of World. The Asia-Pacific is set to grow with the highest CAGR. The regional market’s growth is attributed to the increasing healthcare awareness, the surge in disposable income and government expenditure, and the rise in healthcare spending. Furthermore, domestic enterprises in the Asia-Pacific are fundamentally engaged in the manufacture of low-costing smart syringes for international as well as local usage.
COMPETITIVE INSIGHTS
The global drug delivery market is competitive, with top players involved in continuous partnership alliances and product development to aid market penetration. Moreover, the increasing number of dealers and distributors is set to elevate industry rivalry over the upcoming years.
Some of the key companies operating in the market are Antares Pharma Inc, Baxter International Inc, Johnson & Johnson, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


目次

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. TECHNOLOGICAL ADVANCEMENTS IN DRUG DELIVERY TECHNIQUES
3.1.2. INCREASING USAGE OF BIOLOGICAL DRUGS
3.1.3. GROWING DEMAND FOR EFFECTIVE DRUG DELIVERY MECHANISMS
3.1.4. RISING INCIDENCE OF CHRONIC DISEASES AND PREVAILING AGING POPULATION
3.2. KEY RESTRAINTS
3.2.1. INCREASING DRUG RECALLS AND DRUG FAILURES
3.2.2. GOVERNMENT REGULATIONS DELAYING PROCESSES
3.2.3. SIDE EFFECTS AND RISKS ASSOCIATED WITH THE DRUGS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON DRUG DELIVERY MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. KEY BUYING CRITERIA
4.5. REGULATORY FRAMEWORK
4.6. OPPORTUNITY MATRIX
4.7. VENDOR LANDSCAPE
5. MARKET BY ROUTE OF ADMINISTRATION
5.1. ORAL DRUG DELIVERY
5.1.1.1. SOLID ORAL DRUGS
5.1.1.1.1. TABLETS
5.1.1.1.2. CAPSULES
5.1.1.1.3. POWDERS
5.1.1.1.4. PILLS
5.1.1.2. LIQUID ORAL DRUGS
5.1.1.2.1. SOLUTIONS
5.1.1.2.2. SYRUPS
5.1.1.3. SEMI-SOLID ORAL DRUGS
5.1.1.3.1. ORAL EMULSIONS
5.1.1.3.2. GELS
5.1.1.3.3. ELIXIRS
5.2. INJECTABLE DRUG DELIVERY
5.2.1.1. FORMULATIONS
5.2.1.1.1. CONVENTIONAL DRUG DELIVERY INJECTIONS
5.2.1.1.2. LONG ACTING INJECTABLE
5.2.1.1.3. NOVEL DRUG DELIVERY FORMULATIONS
5.2.1.2. DEVICES
5.2.1.2.1. CONVENTIONAL INJECTION DEVICES
5.2.1.2.1.1. CONVENTIONAL INJECTION DEVICES BY MATERIAL
5.2.1.2.1.1.1. PLASTIC
5.2.1.2.1.1.2. GLASS
5.2.1.2.1.2. CONVENTIONAL INJECTION DEVICES BY PRODUCT
5.2.1.2.1.2.1. FILLABLE SYRINGES
5.2.1.2.1.2.2. PREFILLED SYRINGES
5.2.1.2.1.3. CONVENTIONAL INJECTION DEVICES BY USABILITY
5.2.1.2.1.3.1. DISPOSABLE SYRINGES
5.2.1.2.1.3.2. REUSABLE SYRINGES
5.2.1.2.2. SELF-INJECTION DEVICES
5.2.1.2.2.1. NEEDLE-FREE INJECTORS
5.2.1.2.2.2. PEN INJECTORS
5.2.1.2.2.3. AUTO-INJECTOR
5.2.1.2.2.4. WEARABLE INJECTORS
5.2.1.2.3. OTHER INJECTOR DEVICES
5.3. PULMONARY DRUG DELIVERY
5.3.1.1. DEVICES
5.3.1.1.1. METERED DOSE INHALERS (MDIS)
5.3.1.1.2. NEBULIZERS
5.3.1.1.2.1. JET NEBULIZERS
5.3.1.1.2.2. ULTRASONIC NEBULIZERS DELIVERY
5.3.1.1.2.3. SOFT MIST NEBULIZERS
5.3.1.1.3. DRY POWDER SYSTEM
5.3.1.2. FORMULATIONS
5.4. TOPICAL DRUG DELIVERY
5.4.1.1. FORMULATIONS
5.4.1.1.1. SEMI-SOLID TOPICAL DRUG DELIVERY
5.4.1.1.1.1. CREAMS
5.4.1.1.1.2. OINTMENTS
5.4.1.1.1.3. LOTIONS
5.4.1.1.1.4. GELS
5.4.1.1.1.5. PASTES
5.4.1.1.2. LIQUID TOPICAL DRUG DELIVERY
5.4.1.1.2.1. SOLUTIONS
5.4.1.1.2.2. SUSPENSIONS
5.4.1.1.3. SOLID TOPICAL DRUG DELIVERY
5.4.1.1.3.1. POWDERS
5.4.1.1.3.2. SUPPOSITORIES
5.4.1.2. DEVICES
5.4.1.2.1. TRANSDERMAL PATCHES
5.4.1.2.2. TRANSDERMAL GELS
5.5. NASAL DRUG DELIVERY
5.5.1. NASAL SPRAYS
5.5.2. NASAL DROPS
5.5.3. NASAL GELS
5.5.4. NASAL POWDERS
5.6. OCULAR DRUG DELIVERY
5.6.1. FORMULATIONS
5.6.1.1. LIQUID FORMULATION
5.6.1.1.1. EYE DROPS
5.6.1.1.2. LIQUID SPRAYS
5.6.1.2. SEMI-SOLID FORMULATION
5.6.1.2.1. EYE OINTMENTS
5.6.1.2.2. GELS
5.6.2. OCULAR DEVICES
5.6.2.1. DRUG-COATED CONTACT LENSES
5.6.2.2. OCULAR INSERT
5.7. TRANSMUCOSAL DRUG DELIVERY
5.7.1. ORAL TRANSMUCOSAL DRUG DELIVERY
5.7.1.1. BUCCAL DRUG DELIVERY
5.7.1.2. SUBLINGUAL DRUG DELIVERY
5.7.2. OTHER TRANSMUCOSAL DRUG DELIVERY
5.7.2.1. RECTAL TRANSMUCOSAL DRUG DELIVERY
5.7.2.2. VAGINAL TRANSMUCOSAL DRUG DELIVERY
5.8. IMPLANTABLE DRUG DELIVERY
5.8.1. ACTIVE IMPLANTABLE DRUG DELIVERY
5.8.2. PASSIVE IMPLANTABLE DRUG DELIVERY
6. MARKET BY END-USER
6.1. HOSPITALS
6.2. AMBULATORY SURGICAL CENTERS
6.3. HOME CARE SETTINGS
6.4. OTHER END-USERS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET SIZE & ESTIMATES
7.2.2. KEY GROWTH ENABLERS
7.2.3. KEY CHALLENGES
7.2.4. KEY PLAYERS
7.2.5. COUNTRY ANALYSIS
7.2.5.1. GERMANY
7.2.5.2. FRANCE
7.2.5.3. UNITED KINGDOM
7.2.5.4. ITALY
7.2.5.5. SPAIN
7.2.5.6. RUSSIA
7.2.5.7. POLAND
7.2.5.8. BELGIUM
7.2.5.9. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET SIZE & ESTIMATES
7.3.2. KEY GROWTH ENABLERS
7.3.3. KEY CHALLENGES
7.3.4. KEY PLAYERS
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. AUSTRALIA & NEW ZEALAND
7.3.5.5. SOUTH KOREA
7.3.5.6. INDONESIA
7.3.5.7. THAILAND
7.3.5.8. VIETNAM
7.3.5.9. REST OF ASIA-PACIFIC
7.4. REST OF WORLD
7.4.1. MARKET SIZE & ESTIMATES
7.4.2. KEY GROWTH ENABLERS
7.4.3. KEY CHALLENGES
7.4.4. KEY PLAYERS
7.4.5. REGIONAL ANALYSIS
7.4.5.1. LATIN AMERICA
7.4.5.2. MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. ALKERMES PLC
8.2.2. ANTARES PHARMA INC
8.2.3. BAUSCH HEALTH COMPANIES INC (FORMERLY VALEANT PHARMACEUTICALS)
8.2.4. BAXTER INTERNATIONAL INC
8.2.5. BAYER AG
8.2.6. BECTON, DICKINSON AND COMPANY (BD)
8.2.7. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
8.2.8. BOSTON SCIENTIFIC CORPORATION
8.2.9. GENEREX BIOTECHNOLOGY CORPORATION
8.2.10. GLAXOSMITHKLINE PLC
8.2.11. JOHNSON & JOHNSON
8.2.12. KINDEVA DRUG DELIVERY (FORMERLY 3M DRUG DELIVERY SYSTEMS)
8.2.13. NOVARTIS AG
8.2.14. NOVO NORDISK A/S
8.2.15. TERUMO MEDICAL CORPORATION (MICROVENTION INC)
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – DRUG DELIVERY
TABLE 2: GLOBAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 3: GLOBAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 4: GLOBAL ORAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 5: GLOBAL ORAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 6: GLOBAL SOLID ORAL DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 7: GLOBAL SOLID ORAL DRUGS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 8: GLOBAL LIQUID ORAL DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 9: GLOBAL LIQUID ORAL DRUGS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 10: GLOBAL SEMI-SOLID ORAL DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 11: GLOBAL SEMI-SOLID ORAL DRUGS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 12: GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 13: GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 14: GLOBAL FORMULATIONS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 15: GLOBAL FORMULATIONS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 16: GLOBAL DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 17: GLOBAL DEVICES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 18: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY MATERIAL, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 19: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY MATERIAL, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 20: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 21: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 22: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY USABILITY, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 23: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY USABILITY, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 24: GLOBAL SELF-INJECTION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 25: GLOBAL SELF-INJECTION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 26: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 27: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 28: GLOBAL DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 29: GLOBAL DEVICES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 30: GLOBAL NEBULIZERS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 31: GLOBAL NEBULIZERS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 32: GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 33: GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 34: GLOBAL FORMULATIONS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 35: GLOBAL FORMULATIONS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 36: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 37: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 38: GLOBAL LIQUID TOPICAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 39: GLOBAL LIQUID TOPICAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 40: GLOBAL SOLID TOPICAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 41: GLOBAL SOLID TOPICAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 42: GLOBAL DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 43: GLOBAL DEVICES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 44: GLOBAL NASAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 45: GLOBAL NASAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 46: GLOBAL OCULAR DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 47: GLOBAL OCULAR DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 48: GLOBAL FORMULATIONS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 49: GLOBAL FORMULATIONS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 50: GLOBAL LIQUID FORMULATION MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 51: GLOBAL LIQUID FORMULATION MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 52: GLOBAL SEMI-SOLID FORMULATION MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 53: GLOBAL SEMI-SOLID FORMULATION MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 54: GLOBAL OCULAR DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 55: GLOBAL OCULAR DEVICES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 56: GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 57: GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 58: GLOBAL ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 59: GLOBAL ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 60: GLOBAL OTHER TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 61: GLOBAL OTHER TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 62: GLOBAL IMPLANTABLE DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 63: GLOBAL IMPLANTABLE DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 64: GLOBAL DRUG DELIVERY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 65: GLOBAL DRUG DELIVERY MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 66: GLOBAL DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 67: GLOBAL DRUG DELIVERY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 68: NORTH AMERICA DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 69: NORTH AMERICA DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 70: LEADING PLAYERS OPERATING IN NORTH AMERICA DRUG DELIVERY MARKET
TABLE 71: EUROPE DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 72: EUROPE DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 73: LEADING PLAYERS OPERATING IN EUROPE DRUG DELIVERY MARKET
TABLE 74: ASIA-PACIFIC DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 75: ASIA-PACIFIC DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 76: LEADING PLAYERS OPERATING IN ASIA-PACIFIC DRUG DELIVERY MARKET
TABLE 77: REST OF WORLD DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)
TABLE 78: REST OF WORLD DRUG DELIVERY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ BILLION)
TABLE 79: LEADING PLAYERS OPERATING IN REST OF WORLD DRUG DELIVERY MARKET
TABLE 80: LIST OF MERGERS & ACQUISITIONS
TABLE 81: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 82: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 83: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, IN 2021
FIGURE 6: GLOBAL DRUG DELIVERY MARKET, BY ORAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 7: GLOBAL ORAL DRUG DELIVERY MARKET, BY SOLID ORAL DRUGS, 2022-2030 (IN $ BILLION)
FIGURE 8: GLOBAL SOLID ORAL DRUGS MARKET, BY TABLETS, 2022-2030 (IN $ BILLION)
FIGURE 9: GLOBAL SOLID ORAL DRUGS MARKET, BY CAPSULES, 2022-2030 (IN $ BILLION)
FIGURE 10: GLOBAL SOLID ORAL DRUGS MARKET, BY POWDERS, 2022-2030 (IN $ BILLION)
FIGURE 11: GLOBAL SOLID ORAL DRUGS MARKET, BY PILLS, 2022-2030 (IN $ BILLION)
FIGURE 12: GLOBAL ORAL DRUG DELIVERY MARKET, BY LIQUID ORAL DRUGS, 2022-2030 (IN $ BILLION)
FIGURE 13: GLOBAL LIQUID ORAL DRUGS MARKET, BY SOLUTIONS, 2022-2030 (IN $ BILLION)
FIGURE 14: GLOBAL LIQUID ORAL DRUGS MARKET, BY SYRUPS, 2022-2030 (IN $ BILLION)
FIGURE 15: GLOBAL ORAL DRUG DELIVERY MARKET, BY SEMI-SOLID ORAL DRUGS, 2022-2030 (IN $ BILLION)
FIGURE 16: GLOBAL SEMI-SOLID ORAL DRUGS MARKET, BY ORAL EMULSIONS, 2022-2030 (IN $ BILLION)
FIGURE 17: GLOBAL SEMI-SOLID ORAL DRUGS MARKET, BY GELS, 2022-2030 (IN $ BILLION)
FIGURE 18: GLOBAL SEMI-SOLID ORAL DRUGS MARKET, BY ELIXIRS, 2022-2030 (IN $ BILLION)
FIGURE 19: GLOBAL DRUG DELIVERY MARKET, BY INJECTABLE DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 20: GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY FORMULATIONS, 2022-2030 (IN $ BILLION)
FIGURE 21: GLOBAL FORMULATIONS MARKET, BY CONVENTIONAL DRUG DELIVERY INJECTIONS, 2022-2030 (IN $ BILLION)
FIGURE 22: GLOBAL FORMULATIONS MARKET, BY LONG ACTING INJECTABLE, 2022-2030 (IN $ BILLION)
FIGURE 23: GLOBAL FORMULATIONS MARKET, BY NOVEL DRUG DELIVERY FORMULATIONS, 2022-2030 (IN $ BILLION)
FIGURE 24: GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY DEVICES, 2022-2030 (IN $ BILLION)
FIGURE 25: GLOBAL DEVICES MARKET, BY CONVENTIONAL INJECTION DEVICES, 2022-2030 (IN $ BILLION)
FIGURE 26: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY PLASTIC, 2022-2030 (IN $ BILLION)
FIGURE 27: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY GLASS, 2022-2030 (IN $ BILLION)
FIGURE 28: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY FILLABLE SYRINGES, 2022-2030 (IN $ BILLION)
FIGURE 29: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY PREFILLED SYRINGES, 2022-2030 (IN $ BILLION)
FIGURE 30: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY DISPOSABLE SYRINGES, 2022-2030 (IN $ BILLION)
FIGURE 31: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY REUSABLE SYRINGES, 2022-2030 (IN $ BILLION)
FIGURE 32: GLOBAL DEVICES MARKET, BY SELF-INJECTION DEVICES, 2022-2030 (IN $ BILLION)
FIGURE 33: GLOBAL SELF-INJECTION DEVICES MARKET, BY NEEDLE-FREE INJECTOR, 2022-2030 (IN $ BILLION)
FIGURE 34: GLOBAL SELF-INJECTION DEVICES MARKET, BY PEN INJECTOR, 2022-2030 (IN $ BILLION)
FIGURE 35: GLOBAL SELF-INJECTION DEVICES MARKET, BY AUTO-INJECTOR, 2022-2030 (IN $ BILLION)
FIGURE 36: GLOBAL SELF-INJECTION DEVICES MARKET, BY WEARABLE INJECTOR, 2022-2030 (IN $ BILLION)
FIGURE 37: GLOBAL DEVICES MARKET, BY OTHER INJECTOR DEVICES, 2022-2030 (IN $ BILLION)
FIGURE 38: GLOBAL DRUG DELIVERY MARKET, BY PULMONARY DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 39: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY DEVICES, 2022-2030 (IN $ BILLION)
FIGURE 40: GLOBAL DEVICES MARKET, BY METERED DOSE INHALERS (MDIS), 2022-2030 (IN $ BILLION)
FIGURE 41: GLOBAL DEVICES MARKET, BY NEBULIZERS, 2022-2030 (IN $ BILLION)
FIGURE 42: GLOBAL NEBULIZERS MARKET, BY JET NEBULIZERS, 2022-2030 (IN $ BILLION)
FIGURE 43: GLOBAL NEBULIZERS MARKET, BY ULTRASONIC NEBULIZERS DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 44: GLOBAL NEBULIZERS MARKET, BY SOFT MIST NEBULIZERS, 2022-2030 (IN $ BILLION)
FIGURE 45: GLOBAL DEVICES MARKET, BY DRY POWDER SYSTEM, 2022-2030 (IN $ BILLION)
FIGURE 46: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY FORMULATIONS, 2022-2030 (IN $ BILLION)
FIGURE 47: GLOBAL DRUG DELIVERY MARKET, BY TOPICAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 48: GLOBAL TOPICAL DRUG DELIVERY MARKET, BY FORMULATION, 2022-2030 (IN $ BILLION)
FIGURE 49: GLOBAL FORMULATIONS MARKET, BY SEMI-SOLID TOPICAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 50: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY CREAMS, 2022-2030 (IN $ BILLION)
FIGURE 51: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY OINTMENTS, 2022-2030 (IN $ BILLION)
FIGURE 52: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY LOTIONS, 2022-2030 (IN $ BILLION)
FIGURE 53: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY GELS, 2022-2030 (IN $ BILLION)
FIGURE 54: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY PASTES, 2022-2030 (IN $ BILLION)
FIGURE 55: GLOBAL FORMULATIONS MARKET, BY LIQUID TOPICAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 56: GLOBAL LIQUID TOPICAL DRUG DELIVERY MARKET, BY SOLUTIONS, 2022-2030 (IN $ BILLION)
FIGURE 57: GLOBAL LIQUID TOPICAL DRUG DELIVERY MARKET, BY SUSPENSIONS, 2022-2030 (IN $ BILLION)
FIGURE 58: GLOBAL FORMULATIONS MARKET, BY SOLID TOPICAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 59: GLOBAL SOLID TOPICAL DRUG DELIVERY MARKET, BY POWDERS, 2022-2030 (IN $ BILLION)
FIGURE 60: GLOBAL SOLID TOPICAL DRUG DELIVERY MARKET, BY SUPPOSITORIES, 2022-2030 (IN $ BILLION)
FIGURE 61: GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DEVICES, 2022-2030 (IN $ BILLION)
FIGURE 62: GLOBAL DEVICES MARKET, BY TRANSDERMAL PATCHES, 2022-2030 (IN $ BILLION)
FIGURE 63: GLOBAL DEVICES MARKET, BY TRANSDERMAL GELS, 2022-2030 (IN $ BILLION)
FIGURE 64: GLOBAL DRUG DELIVERY MARKET, BY NASAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 65: GLOBAL NASAL DRUG DELIVERY MARKET, BY NASAL SPRAYS, 2022-2030 (IN $ BILLION)
FIGURE 66: GLOBAL NASAL DRUG DELIVERY MARKET, BY NASAL DROPS, 2022-2030 (IN $ BILLION)
FIGURE 67: GLOBAL NASAL DRUG DELIVERY MARKET, BY NASAL GELS, 2022-2030 (IN $ BILLION)
FIGURE 68: GLOBAL NASAL DRUG DELIVERY MARKET, BY NASAL POWDERS, 2022-2030 (IN $ BILLION)
FIGURE 69: GLOBAL DRUG DELIVERY MARKET, BY OCULAR DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 70: GLOBAL OCULAR DRUG DELIVERY MARKET, BY FORMULATIONS, 2022-2030 (IN $ BILLION)
FIGURE 71: GLOBAL FORMULATION MARKET, BY LIQUID FORMULATION, 2022-2030 (IN $ BILLION)
FIGURE 72: GLOBAL LIQUID FORMULATION MARKET, BY EYE DROPS, 2022-2030 (IN $ BILLION)
FIGURE 73: GLOBAL LIQUID FORMULATION MARKET, BY LIQUID SPRAYS, 2022-2030 (IN $ BILLION)
FIGURE 74: GLOBAL FORMULATION MARKET, BY SEMI-SOLID FORMULATION, 2022-2030 (IN $ BILLION)
FIGURE 75: GLOBAL SEMI-SOLID FORMULATION MARKET, BY EYE OINTMENTS, 2022-2030 (IN $ BILLION)
FIGURE 76: GLOBAL SEMI-SOLID FORMULATION MARKET, BY GELS, 2022-2030 (IN $ BILLION)
FIGURE 77: GLOBAL OCULAR DRUG DELIVERY MARKET, BY OCULAR DEVICES, 2022-2030 (IN $ BILLION)
FIGURE 78: GLOBAL OCULAR DEVICES MARKET, BY DRUG-COATED CONTACT LENSES, 2022-2030 (IN $ BILLION)
FIGURE 79: GLOBAL OCULAR DEVICES MARKET, BY OCULAR INSERT, 2022-2030 (IN $ BILLION)
FIGURE 80: GLOBAL DRUG DELIVERY MARKET, BY TRANSMUCOSAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 81: GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY ORAL TRANSMUCOSAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 82: GLOBAL ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY BUCCAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 83: GLOBAL ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY SUBLINGUAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 84: GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY OTHER TRANSMUCOSAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 85: GLOBAL OTHER TRANSMUCOSAL DRUG DELIVERY MARKET, BY RECTAL TRANSMUCOSAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 86: GLOBAL OTHER TRANSMUCOSAL DRUG DELIVERY MARKET, BY VAGINAL TRANSMUCOSAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 87: GLOBAL DRUG DELIVERY MARKET, BY IMPLANTABLE DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 88: GLOBAL IMPLANTABLE DRUG DELIVERY MARKET, BY ACTIVE IMPLANTABLE DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 89: GLOBAL IMPLANTABLE DRUG DELIVERY MARKET, BY PASSIVE IMPLANTABLE DRUG DELIVERY, 2022-2030 (IN $ BILLION)
FIGURE 90: GLOBAL DRUG DELIVERY MARKET, BY END-USER, IN 2021
FIGURE 91: GLOBAL DRUG DELIVERY MARKET, BY HOSPITALS, 2022-2030 (IN $ BILLION)
FIGURE 92: GLOBAL DRUG DELIVERY MARKET, BY AMBULATORY SURGICAL CENTERS, 2022-2030 (IN $ BILLION)
FIGURE 93: GLOBAL DRUG DELIVERY MARKET, BY HOME CARE SETTINGS, 2022-2030 (IN $ BILLION)
FIGURE 94: GLOBAL DRUG DELIVERY MARKET, BY OTHER END-USERS, 2022-2030 (IN $ BILLION)
FIGURE 95: NORTH AMERICA DRUG DELIVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 96: UNITED STATES DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 97: CANADA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 98: EUROPE DRUG DELIVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 99: GERMANY DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 100: FRANCE DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 101: UNITED KINGDOM DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 102: ITALY DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 103: SPAIN DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 104: RUSSIA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 105: POLAND DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 106: BELGIUM DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 107: REST OF EUROPE DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 108: ASIA-PACIFIC DRUG DELIVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 109: CHINA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 110: JAPAN DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 111: INDIA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 112: AUSTRALIA & NEW ZEALAND DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 113: SOUTH KOREA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 114: INDONESIA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 115: THAILAND DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 116: VIETNAM DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 117: REST OF ASIA-PACIFIC DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 118: REST OF WORLD DRUG DELIVERY MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
FIGURE 119: LATIN AMERICA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)
FIGURE 120: MIDDLE EAST & AFRICA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com